
Tritide25 mcg+62.
Unimed Unihealth MFG. Ltd.
Vilanterol + Umeclidinium and Fluticasone Furote is a fixed-dose triple combination inhaled medicine used as long-term and more.
Vilanterol + Umeclidinium and Fluticasone Furote is a fixed-dose triple combination inhaled medicine used as long-term, once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD).
| Indication | Recommended Dose |
|---|---|
| Maintenance treatment of COPD (adults) | One inhalation once daily, at the same time each day, using the specific strength of Vilanterol + Umeclidinium and Fluticasone Furote prescribed. |
The maximum recommended dose is one inhalation once daily; do not use more than one inhalation in a 24-hour period.
The most commonly reported side effects of Vilanterol + Umeclidinium and Fluticasone Furote include:
Less common but clinically important effects include palpitations, tremor, tachycardia, dysgeusia (altered taste), constipation, dry mouth, and urinary retention. See Precautions and Warnings for serious risks such as paradoxical bronchospasm, pneumonia, and cardiovascular effects.
Vilanterol + Umeclidinium and Fluticasone Furote is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.